Meningitis is one of the major threats to prenatal and newborn babies, causing more than 300,000 infant deaths worldwide annually. Survivors often suffer from long-term neuron-developmental disorders caused by the infection [[1], [2], [3]]. Bacterial meningitis, a prevalent form of this condition, remains a major global public health challenge, despite significant progress in combating specific pathogens [4]. In infants, where systemic adaptive immunity is not fully developed, brain macrophage plays a crucial role in defensing pathogen infection in this vital organ [5,6]. However, our understanding of the precise markers that reflect the distinct contributions of various macrophage populations in the neonatal brain remains incomplete.
Elsevier, hLife, Volume 2, July 2024
